MICHELLE ALBONETTI WALKER: Open Payments
NPI 1356787592 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 41 payments from 16 companies in 2025. Trend: 2023 $61 · 2024 $611 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $140 |
| Amgen Inc. | 7 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| ABBVIE INC. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Abbott Laboratories | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $32 |
Products named: Kerendia, REXULTI, Ozempic, OTEZLA, Rybelsus, REPATHA, VOQUEZNA, FREESTYLE LIBRE 3.
Industry payments across TN — which companies pay providers there.
